Evidence map›Paper›PMID 27599520›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2017

Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South London.

Natalie Thurtle, Rachelle Abouchedid, John R H Archer, James Ho, Takahiro Yamamoto, Paul I Dargan, David M Wood

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. An Internet Snapshot Survey Assessing the sale of Synthetic Cannabinoid Receptor Agonists for use with Electronic Vaping Devices.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Identification of Gamma-Butyrolactone in JUUL Liquids.Journal of analytical toxicology · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Natalie ThurtleClinical Toxicology, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK. nat_thurtle@yahoo.com.ORCID 0000-0001-6754-7340
Rachelle AbouchedidClinical Toxicology, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
John R H ArcherClinical Toxicology, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
James HoClinical Toxicology, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
Takahiro YamamotoClinical Toxicology, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
Paul I DarganClinical Toxicology, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
David M WoodClinical Toxicology, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
Guy's and St Thomas' NHS Foundation Trust · GBKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionElectronic nicotine delivery systems (ENDS, often called e-cigarettes) are nicotine delivery devices that heat nicotine into vapour that is inhaled, a process called 'vaping'. Use eclipsed nicotine-replacement therapy (NRT) in 2014 but ENDS role in smoking cessation remains controversial. Safety has not been proven and there have been reports to US poison centres regarding potential ENDS-related nicotine toxicity. A further concern is use of ENDS to vape recreational drugs, but there is limited data to substantiate this. The aim of this study was to report on ENDS use to vape recreational drugs in patrons of a South London nightclub where high prevalence of recreational drug use has previously been shown.

methodsA convenience sample of 101 participants was surveyed in March 2015 as part of a larger survey on drug use. Individuals were asked if they used ENDS to vape nicotine and/or other substances (and if so which substances).

resultsNinety (89.1 %) of respondents were male with median age of 28 years (IQR 23-34). Eighty (79.2 %) currently smoked cigarettes; 20 (19.8 %) currently used ENDS for nicotine. Six (5.9 %) reported using ENDS to take other substances: 2 for 'liquid cannabis' and 4 did not elaborate on the substance(s) used. Of these 6, 3 were using ENDS to vape nicotine and 3 had never used them for nicotine.

conclusion5.9 % of individuals in this sample reported using ENDS to vape substances other than nicotine. Further work is required in larger populations to determine how common this is, evaluate which agents are being vaped and to inform appropriate public education.

Indexed as

AdultCannabisElectronic Nicotine Delivery SystemsFemaleHomosexualityHumansLondonMaleNicotinePrevalenceSmokingSocioeconomic FactorsSubstance-Related DisordersSurveys and QuestionnairesVapingYoung AdultNicotineE-cigarettesElectronic nicotine delivery systemsRecreational drugsVaping

Identifiers

PMID27599520
PMCPMC5330959
OpenAlexW2508630239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.